MobileODT

AI-based Cervical Cancer Screening Solutions

Health Tech & Life Sciences
Active
Mature Tel Aviv-Yafo, Israel Founded 2012
Last updated 2026-06-18
Total raised
$22.5M
Last: Grant 2021-01
Stage
Mature
Founded
2012
Headcount
10
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

MobileODT develops optical diagnostic devices and software services designed for early cancer detection and a range of other medical purposes. The company is creating advanced optical technology components to turn smartphones into easy-to-use mobile point-of-care tools to help detect cancer and capture a range of biomedical images for diagnostic and other analytical purposes.

Mobile ODT also develops intuitive app-based programs to operate its devices and connect them to a cloud-based software platform. The platform will enable immediate remote consultation with experts for improved case management and easy integration with a range of emerging electronic health record programs.

The company’s EVA COLPO is an FDA-cleared, internet-connected portable colposcope that is as simple to use as a mobile phone. The device combines advanced hardware with integrated software to serve a variety of clinical needs.

The EVA SANE is a secure and easy-to-use forensic documentation system for fast examinations. It combines the capabilities of a video colposcope and a digital camera to enable both full-body and external body cavity image and video capture. The EVA WELL is an FDA-cleared and HIPAA-compliant digital visualization tool for gynecologic exams.

Funding history · 7 rounds · $22.5M total

Q&A

What is MobileODT's primary focus?
MobileODT specializes in AI-based cervical cancer screening solutions, developing optical diagnostic devices and software for early cancer detection and other medical purposes.
When was MobileODT founded?
MobileODT was founded in October 2012.
What is MobileODT's total funding to date?
MobileODT has raised a total of $22,475,000 in funding.
Which investors participated in MobileODT's August 2020 funding round?
In August 2020, MobileODT received funding from OrbiMed and Tristel.
What is the latest funding round MobileODT received?
MobileODT received a Grant in January 2021, with funding from the National Cancer Institute.
What are some of MobileODT's key products?
MobileODT offers products such as EVA COLPO, an FDA-cleared portable colposcope; EVA SANE, a forensic documentation system; and EVA WELL, an FDA-cleared digital visualization tool for gynecologic exams.
Where is MobileODT's headquarters located?
MobileODT's headquarters is located in Tel Aviv-Yafo, Israel.

Team · 2

Founder · Co-founder (No longer with the company)
LinkedIn ↗
Founder · Co-founder (No longer with the company)
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Platforms & InterfacesSoftwareArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

Verified

Tags

non-invasiveearly-detectiondigital-healthcarewomen-healthmhealthdoctorselectro-opticsimagingdiagnosticsmachine-learningdata-analyticscanceroncologyhospitalsmobile-applicationshealthcare-providersclinical-trialsimage-processingdecision-supportartificial-intelligencetelehealthmedical-technologiesoptronicsclinicspatient-engagementwomenfemtech
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)